Reduced-Fluence Photodynamic Therapy Combined with Ranibizumab for Nonproliferative Macular Telangiectasia Type 2
2013 ◽
Vol 23
(1)
◽
pp. 1-6
◽
2016 ◽
Vol 101
(7)
◽
pp. 955-959
◽